INDICATIONS FOR HCV (HEPATITIS C VIRUS) THERAPY
Thursday, March 10th, 2011INDICATIONS FOR HCV (HEPATITIS C VIRUS) THERAPYTreatment is typically recommended for patients with chronic hepatitis С who are at the greatest risk for progression to cirrhosis. The risks and benefits of treatment must be assessed for each patient, particularly given the slow course of natural infection. In general, treatment may be recommended for patients with the following conditions:- Moderate liver disease – Persistently elevated ALT levels, HCV viremia, and liver biopsy demonstrating at least moderate inflammation (at least grade 2) and fibrosis (at least stage 1).- Mild liver disease – Elevated ALT levels, HCV viremia, and only mild inflammatory changes (grades 1 to 2, stage 0) on liver biopsy. Observation may also be reasonable in these instances.- Compensated cirrhosis -These patients may have a higher rate of side effects from therapy.- HIV co-infectionPatients with persistently normal ALT levels and minimal or no histologic evidence of inflammation have an excellent prognosis without therapy. Patients with decompensated cirrhosis should not be treated, since they are unlikely to have a response and their condition may worsen with therapy. Pregnancy is an absolute contraindication to HCV treatment. Little is known about the treatment of HCV in children and adolescents, and further research is needed.*84/348/5*